Form 4 for NTLA Intellia Therapeutics, Inc.
Accepted 2025-01-31 00:00:00 ET · period of report 2025-01-29 · accession 0000950170-25-011757 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2025-01-31 | 2025-01-29 | NTLA | Bhanji Muna | Dir | S - Sale | $9.97 | -265 | 19.5K | -1% | -$2,642 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-29 | S | D | 265 | $9.97 | 19,468 | D | — | — |